{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:11:48Z","timestamp":1789755108500,"version":"4.0.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005629","name":"Takeda Pharmaceuticals USA Inc Lexington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005629","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","intestinalfailurejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Intestinal Failure"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.intf.2026.100387","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:01:18Z","timestamp":1789466478000},"page":"100387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effectiveness, safety, and quality of life outcomes of teduglutide treatment in adult patients with short bowel syndrome-associated intestinal failure: A systematic literature review of real-world studies"],"prefix":"10.1016","volume":"12","author":[{"given":"Shirley C.","family":"Paski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Becher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Nazarey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1446-3271","authenticated-orcid":false,"given":"Kishore","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intf.2026.100387_bib1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clnu.2016.01.020","article-title":"ESPEN guidelines on chronic intestinal failure in adults","volume":"35","author":"Pironi","year":"2016","journal-title":"Clin Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib2","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.cgh.2022.05.032","article-title":"AGA clinical practice update on management of short bowel syndrome: Expert review","volume":"20","author":"Iyer","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.intf.2026.100387_bib3","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.clnu.2023.07.019","article-title":"ESPEN guideline on chronic intestinal failure in adults \u2013 update 2023","volume":"42","author":"Pironi","year":"2023","journal-title":"Clin Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib4","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2147\/PPA.S443026","article-title":"A systematic review of quality of life in patients with short bowel syndrome and their caregivers","volume":"18","author":"Chen","year":"2024","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.intf.2026.100387_bib5","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/jpen.1958","article-title":"High parenteral support volume is associated with reduced quality of life determined by the Short-Bowel Syndrome Quality of Life scale in nonmalignant intestinal failure patients","volume":"45","author":"Nordsten","year":"2021","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0261-5614(03)00042-6","article-title":"Quality of life and concerns in patients with short bowel syndrome","volume":"22","author":"Carlsson","year":"2003","journal-title":"Clin Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cgh.2005.10.002","article-title":"Short bowel syndrome and intestinal failure: consensus definitions and overview","volume":"4","author":"O'Keefe","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.intf.2026.100387_bib8","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3390\/nu15030628","article-title":"The role of a colon-in-continuity in short bowel syndrome","volume":"15","author":"Verbiest","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.intf.2026.100387_bib9","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/0148607116680791","article-title":"Independence from parenteral nutrition and intravenous fluid support during treatment with teduglutide among patients with intestinal failure associated with short bowel syndrome","volume":"41","author":"Iyer","year":"2017","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib10","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/gut.2010.218271","article-title":"Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and\/or intravenous fluid requirements in patients with short bowel syndrome","volume":"60","author":"Jeppesen","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.intf.2026.100387_bib11","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1053\/j.gastro.2012.09.007","article-title":"Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure","volume":"143","author":"Jeppesen","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intf.2026.100387_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2015.69","article-title":"Long-term teduglutide for the treatment of patients with intestinal failure associated with short bowel syndrome","volume":"7","author":"Schwartz","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.intf.2026.100387_bib13","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ncp.10092","article-title":"Reduction of parenteral nutrition and hydration support and safety with long-term teduglutide treatment in patients with short bowel syndrome-associated intestinal failure: STEPS-3 study","volume":"33","author":"Seidner","year":"2018","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.intf.2026.100387_bib14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.clnu.2013.03.016","article-title":"Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide \u2013 analyses from a randomised, placebo-controlled study","volume":"32","author":"Jeppesen","year":"2013","journal-title":"Clin Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib15","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/j.gastro.2017.11.023","article-title":"Factors associated with response to teduglutide in patients with short-bowel syndrome and intestinal failure","volume":"154","author":"Jeppesen","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intf.2026.100387_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.12869","article-title":"Feasibility of using real-world data to replicate clinical trial evidence","volume":"2","author":"Bartlett","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.intf.2026.100387_bib17","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3390\/nu14040796","article-title":"Efficacy of teduglutide for parenteral support reduction in patients with short bowel syndrome: a systematic review and meta-analysis","volume":"14","author":"Bioletto","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.intf.2026.100387_bib18","doi-asserted-by":"crossref","first-page":"S741","DOI":"10.1016\/S0016-5085(21)02482-3","article-title":"Real-world effectiveness and safety of teduglutide in adult short bowel syndrome: a meta-analysis","volume":"160","author":"Paski","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intf.2026.100387_bib19","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.12669\/pjms.41.9.12604","article-title":"Safety of Teduglutide for Managing Patients with Short Bowel Syndrome: A Systematic Review and Meta-analysis","volume":"41","author":"Liu","year":"2025","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.intf.2026.100387_bib20","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.intf.2026.100387_bib21","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.intf.2026.100387_bib22","unstructured":"McKenzie J.E., Brennan S.E. Cochrane Training. Chapter 12: synthesizing and presenting findings using other methods. Available at https:\/\/training.cochrane.org\/handbook\/current\/chapter-12. Accessed June 30, 2024."},{"key":"10.1016\/j.intf.2026.100387_bib23","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3390\/nu15081949","article-title":"Quality of life in teduglutide-treated patients with short bowel syndrome intestinal failure \u2013 a nested matched pair real-world study","volume":"15","author":"Bl\u00fcthner","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.intf.2026.100387_bib24","doi-asserted-by":"crossref","DOI":"10.1097\/01.tp.0000945788.96626.15","article-title":"Abstract 83. Long term reduction in parenteral support requirements with teduglutide therapy in short bowel syndrome-intestinal failure","volume":"107","author":"Chapman","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.intf.2026.100387_bib25","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1177\/0148607115594010","article-title":"Clinical management of patients with parenteral nutrition-dependent short bowel syndrome during teduglutide therapy","volume":"40","author":"Compher","year":"2016","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib26","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/jpen.2549","article-title":"Adult patients with short bowel syndrome treated with teduglutide: a descriptive cohort study","volume":"47","author":"Daoud","year":"2023","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib27","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.ajcnut.2023.02.015","article-title":"Unexpected upper gastrointestinal polyps in patients with short bowel syndrome treated with teduglutide: need for close monitoring","volume":"117","author":"de Dreuille","year":"2023","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib28","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.3390\/nu15112448","article-title":"Post-marketing use of teduglutide in a large cohort of adults with short bowel syndrome-associated chronic intestinal failure: evolution and outcomes","volume":"15","author":"de Dreuille","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.intf.2026.100387_bib29","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.3390\/jcm13051238","article-title":"Evaluation of the effectiveness of teduglutide treatment in patients with short bowel syndrome in Slovakia \u2013 multicenter real-world study","volume":"13","author":"Gombo\u0161ov\u00e1","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.intf.2026.100387_bib30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.tp.0000945704.64296.38","article-title":"Abstract 62. Long-term safety analysis of teduglutide treatment in adult patients with short bowel syndrome and intestinal failure (SBS-IF): analysis from a prospective, multinational SBS-IF registry","volume":"107","author":"Gondolesi","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.intf.2026.100387_bib31","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/jpen.1686","article-title":"Results of surgical and medical rehabilitation for adult patients with type III intestinal failure in a comprehensive unit today: building a new model to predict parenteral nutrition independency","volume":"44","author":"Gondolesi","year":"2020","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.clnesp.2022.08.027","article-title":"Long-term results of teduglutide treatment for chronic intestinal failure \u2013 insights from a national, multi-centric patient home-care service program","volume":"51","author":"Greif","year":"2022","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.intf.2026.100387_bib33","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/jpen.2272","article-title":"Teduglutide in short bowel syndrome patients: a way back to normal life?","volume":"46","author":"Harpain","year":"2022","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib34","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.clnesp.2022.09.437","article-title":"Abstract P351. Clinical characteristics of chronic intestinal failure in the United States \u2013 analysis of a third party payer claims database","volume":"54","author":"Iyer","year":"2023","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.intf.2026.100387_bib35","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1016\/j.clnu.2019.12.019","article-title":"Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: a real-world French observational cohort study","volume":"39","author":"Joly","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.clnesp.2022.09.131","article-title":"Abstract PT37. Long-term safety analysis of teduglutide treatment in adult patients with short bowel syndrome and intestinal failure","volume":"54","author":"Joly","year":"2023","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.intf.2026.100387_bib37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/ajhp\/zxad274","article-title":"Long-term outcomes and adverse effects of teduglutide in patients with short bowel syndrome: highlighting hyperamylasemia and hyperlipasemia","volume":"81","author":"Kim","year":"2024","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.intf.2026.100387_bib38","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/MCG.0000000000000604","article-title":"Safety and efficacy of teduglutide (Gattex) in patients with Crohn's disease and need for parenteral support due to short bowel syndrome-associated intestinal failure","volume":"51","author":"Kochar","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.intf.2026.100387_bib39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jpen.1011","article-title":"Single-center experience with the use of teduglutide in adult patients with short bowel syndrome","volume":"42","author":"Lam","year":"2018","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib40","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/jpen.2221","article-title":"Characterization of American teduglutide consumers from 2015 to 2020: a large database study","volume":"46","author":"Loutfy","year":"2022","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib41","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.clnesp.2023.09.517","article-title":"Abstract P077-W. Real-life multicenter experience with teduglutide in adults with short bowel syndrome and chronic intestinal failure","volume":"58","author":"Maiz Jimenez","year":"2023","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.intf.2026.100387_bib42","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/ajcn\/nqaa412","article-title":"Imaging as predictor of clinical response to teduglutide in adult patients with short bowel syndrome with chronic intestinal failure","volume":"113","author":"Martin","year":"2021","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib43","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.clnesp.2023.09.868","article-title":"Abstract LB24-W. 30 years of Czech national home parenteral nutrition registry: analysis of current data and trends of patients with nonmalignant short bowel syndrome","volume":"58","author":"Ouradova","year":"2023","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.intf.2026.100387_bib44","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.clnesp.2022.09.335","article-title":"Abstract P215. Long-term effectiveness of teduglutide treatment in adult patients with short bowel syndrome and intestinal failure","volume":"54","author":"Pape","year":"2023","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.intf.2026.100387_bib45","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.clnu.2018.07.030","article-title":"Experience with teduglutide treatment for short bowel syndrome in clinical practice","volume":"38","author":"Pevny","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib46","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.clnesp.2022.09.263","article-title":"Abstract P134. Use of teduglutide in the treatment of chronic intestinal failure associated with short bowel syndrome in adults: real-life experience of the IICB Reference Centre of the AOU Citt\u00e0 della Salute e della Scienza of Turin","volume":"54","author":"Pira","year":"2023","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.intf.2026.100387_bib47","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/jpen.1838","article-title":"Long-term outcomes with teduglutide from a single center","volume":"45","author":"Puello","year":"2021","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib48","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.clnu.2023.03.012","article-title":"Short-term clinical evaluation of teduglutide for patients with Crohn's disease on home parenteral support for postoperative short bowel syndrome with intestinal failure","volume":"42","author":"Sato","year":"2023","journal-title":"Clin Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib49","doi-asserted-by":"crossref","DOI":"10.1177\/1756284818793343","article-title":"GLP-2 analog teduglutide significantly reduces need for parenteral nutrition and stool frequency in a real-life setting","volume":"11","author":"Schoeler","year":"2018","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.intf.2026.100387_bib50","article-title":"Improved outcomes associated with teduglutide use in patients with both short bowel syndrome and Crohn's disease","volume":"6","author":"Siu","year":"2024","journal-title":"Crohns Colitis 360"},{"key":"10.1016\/j.intf.2026.100387_bib51","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/jpen.1983","article-title":"Postsurgical intestinal rehabilitation using semisynthetic glucagon-like peptide-2 analogue (sGLP-2) at a referral center: can patients achieve parenteral nutrition and sGLP-2 independency?","volume":"45","author":"Solar","year":"2021","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib52","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.clnesp.2022.09.279","article-title":"Abstract P151. Real-world study of the safety and effectiveness of teduglutide in adult and pediatric patients with short bowel syndrome in Argentina. An interim analysis","volume":"54","author":"Solar Mu\u00f1iz","year":"2023","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.intf.2026.100387_bib53","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/jpen.1149","article-title":"Long-term therapy with teduglutide in parenteral support-dependent patients with short bowel syndrome: a case series","volume":"42","author":"Ukleja","year":"2018","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib54","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nbt0213-92b","article-title":"First drug for short-bowel","volume":"31","author":"Dorey","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.intf.2026.100387_bib55","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1002\/ncp.10991","article-title":"Anatomical and physiological considerations in short bowel syndrome: Emphasis on intestinal adaptation and the role of enterohormones","volume":"38","author":"Tappenden","year":"2023","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.intf.2026.100387_bib56","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/jpen.2040","article-title":"Home parenteral nutrition patient-reported outcome questionnaire: Sensitive to quality of life differences among chronic and prolonged acute intestinal failure patients","volume":"45","author":"Winkler","year":"2021","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib57","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.14309\/00000434-201210001-00330","article-title":"Long term therapy with teduglutide: Characteristics of patients with short bowel syndrome who achieve complete independence from parenteral nutrition and\/or intravenous fluid support","volume":"107","author":"Fujioka","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.intf.2026.100387_bib58","article-title":"Characteristics of patients with intestinal failure associated with short bowel syndrome who achieved independence from parenteral support during treatment with teduglutide","volume":"99","author":"Jeppesen","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.intf.2026.100387_bib59","first-page":"A1","article-title":"Safety and efficacy of long-term teduglutide treatment: Findings from a 2-year, open-label extension trial, STEPS-2","volume":"2","author":"Jeppesen","year":"2014","journal-title":"U Eur Gastroenterol J"},{"key":"10.1016\/j.intf.2026.100387_bib60","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jpen.1687","article-title":"Enteral autonomy and days off parenteral support with teduglutide treatment for short bowel syndrome in the STEPS trials","volume":"44","author":"Seidner","year":"2020","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib61","first-page":"A110","article-title":"PTU-111\u2005Teduglutide reduces the need for parenteral support in patients with short bowel syndrome who have ultra-short remnant bowel and\/or no colon-in-continuity","volume":"65","author":"Gabe","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.intf.2026.100387_bib62","doi-asserted-by":"crossref","first-page":"S259","DOI":"10.14309\/00000434-201610001-00565","article-title":"Predictors of response to teduglutide among patients with parenteral nutrition-dependent short bowel syndrome","volume":"111","author":"Seidner","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.intf.2026.100387_bib63","first-page":"S650","article-title":"Results of a post hoc analysis of baseline characteristics and clinical response to teduglutide in patients with short bowel syndrome based on residual bowel anatomy: 1183","volume":"112","author":"Jeppesen","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.intf.2026.100387_bib64","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.clnesp.2021.03.011","article-title":"Predictors and timing of response to teduglutide in patients with short bowel syndrome dependent on parenteral support","volume":"43","author":"Chen","year":"2021","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.intf.2026.100387_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1439781","article-title":"The real-world analysis of adverse events with teduglutide: a pharmacovigilance study based on the FAERS database","volume":"15","author":"Wang","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.intf.2026.100387_bib66","unstructured":"U.S Food and Drug Administration. FDA Adverse Event Reporting System (FAERS) Public Dashboard. Available from: https:\/\/www.fda.gov\/drugs\/fdas-adverse-event-reporting-system-faers\/fda-adverse-event-reporting-system-faers-public-dashboard. Accessed: October 23, 2025."},{"key":"10.1016\/j.intf.2026.100387_bib67","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF03404342","article-title":"Health-related quality of life in Canadian adolescents and young adults: normative data using the SF-36","volume":"100","author":"Hopman","year":"2009","journal-title":"Can J Public Health"},{"key":"10.1016\/j.intf.2026.100387_bib68","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/jpen.2372","article-title":"Impact of intestinal failure and parenteral support on adult patients with short-bowel syndrome: A multinational, noninterventional, cross-sectional survey","volume":"46","author":"Jeppesen","year":"2022","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib69","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/jpen.2248","article-title":"Impact on caregivers of adult patients receiving parenteral support for short-bowel syndrome with intestinal failure: A multinational, cross-sectional survey","volume":"46","author":"Jeppesen","year":"2022","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib70","first-page":"457","article-title":"Intestinal adaptation and rehabilitation in adults with short bowel syndrome","volume":"27","author":"Pironi","year":"2024","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.intf.2026.100387_bib71","first-page":"12","article-title":"The clinician\u2019s toolkit for the adult short bowel patient part ii: Pharmacologic interventions","volume":"46","author":"Kumpf","year":"2022","journal-title":"Pract Gastroenterol"},{"key":"10.1016\/j.intf.2026.100387_bib72","first-page":"600","article-title":"Managing the adult patient with short bowel syndrome","volume":"13","author":"Parrish","year":"2017","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.intf.2026.100387_bib73","doi-asserted-by":"crossref","first-page":"38S","DOI":"10.1177\/0148607113520618","article-title":"Pharmacologic Management of Diarrhea in Patients With Short Bowel Syndrome","volume":"38","author":"Kumpf","year":"2014","journal-title":"J Parenter Enter Nutr"},{"key":"10.1016\/j.intf.2026.100387_bib74","unstructured":"SEER Incidence Data\u00a0November 2024 Submission (1975-2022). SEER 21 Registries. Available from: https:\/\/seer.cancer.gov\/data\/ Accessed: 19 May 2025."},{"key":"10.1016\/j.intf.2026.100387_bib75","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(19)32545-0","article-title":"Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study","volume":"395","author":"Ol\u00e9n","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.intf.2026.100387_bib76","unstructured":"Takeda Pharmaceuticals U.S.A., Inc. GATTEX Prescribing Information. 2025. Available from: https:\/\/www.shirecontent.com\/PI\/PDFs\/Gattex_USA_ENG.pdf. Accessed May 14, 2025."},{"key":"10.1016\/j.intf.2026.100387_bib77","article-title":"An interim analysis of colorectal cancer cases from a global registry of adults with short bowel syndrome and intestinal failure receiving teduglutide","volume":"6","author":"Jeppesen","year":"2025","journal-title":"Intest Fail"}],"container-title":["Intestinal Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950456226000370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950456226000370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:55:07Z","timestamp":1789754107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950456226000370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":77,"alternative-id":["S2950456226000370"],"URL":"https:\/\/doi.org\/10.1016\/j.intf.2026.100387","relation":{},"ISSN":["2950-4562"],"issn-type":[{"value":"2950-4562","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness, safety, and quality of life outcomes of teduglutide treatment in adult patients with short bowel syndrome-associated intestinal failure: A systematic literature review of real-world studies","name":"articletitle","label":"Article Title"},{"value":"Intestinal Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intf.2026.100387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Takeda Pharmaceuticals USA, Inc.. Published by Elsevier Inc on behalf of International Intestinal Rehabilitation & Transplant Association.","name":"copyright","label":"Copyright"}],"article-number":"100387"}}